Midazolam Hydrochloride
Brands: Midazolam · Midazolam Hydrochloride
14 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Brands: Midazolam · Midazolam Hydrochloride
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hospira, Inc. | unknown | 11 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 10 | SUPPLYING |
| Somerset Therapeutics, LLC | unknown | 4 | SUPPLYING |
| ONESOURCE SPECIALTY PHARMA LIMITED | unknown | 4 | SUPPLYING |
| Gland Pharma Limited | unknown | 3 | SUPPLYING |
| Steriscience Specialties Private Limited | unknown | 3 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | unknown | 3 | SUPPLYING |
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 2 | SUPPLYING |
| Henry Schein, Inc. | unknown | 2 | SUPPLYING |
| Belcher Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
| Jvet Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Midazolam Hydrochloride Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Anesthesia, Neurology.
Midazolam Hydrochloride Injection — reported in shortage by Avet Pharmaceuticals, Inc.. Therapeutic category: Anesthesia, Neurology.
Midazolam Hydrochloride Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia, Neurology.
Midazolam Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Anesthesia, Neurology.
Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL — Recalling firm: Fresenius Kabi USA, LLC — Nationwide in the USA
Failed Impurities/Degradation Specifications — Recalling firm: Fresenius Kabi USA, LLC — Nationwide and Puerto Rico
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles. — Recalling firm: Fresenius Kabi USA, LLC — U.S. Nationwide Including Puerto Rico